Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Yesterday, two groups announced the submission of applications seeking FDA approval of biosimilars of Herceptin® (trastuzumab), which is indicated for the treatment of HER2-positive early breast cancer, adjuvant breast...more